Cresomycin

An antibiotic compound

Cresomycin
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Cresomycin is an antibiotic compound that was originally isolated from the bacterium Streptomyces species. It is known for its activity against certain bacterial infections, particularly those caused by Mycobacterium tuberculosis, the causative agent of tuberculosis.

Chemical Structure

Chemical structure of Cresomycin

Cresomycin is a complex molecule with a unique structure that contributes to its antibiotic properties. The structure of cresomycin includes several distinct functional groups that are crucial for its biological activity. The presence of these groups allows cresomycin to interact with bacterial ribosomes, inhibiting protein synthesis and thereby exerting its antibacterial effects.

Mechanism of Action

Cresomycin functions primarily by binding to the bacterial ribosome, a critical component of the protein synthesis machinery in bacteria. By interfering with the ribosomal function, cresomycin effectively halts the production of essential proteins required for bacterial growth and replication. This mechanism is similar to that of other antibiotics such as aminoglycosides, although cresomycin has a distinct binding site and mode of action.

Clinical Use

Cresomycin has been studied for its potential use in treating tuberculosis, especially in cases where the bacteria have developed resistance to other antibiotics. Its ability to target Mycobacterium tuberculosis makes it a valuable candidate for inclusion in multi-drug regimens aimed at combating resistant strains of the bacterium.

Production and Isolation

Cresomycin is produced by certain strains of the Streptomyces genus, which are well-known for their ability to synthesize a wide variety of antibiotics. The isolation of cresomycin involves culturing these bacteria under specific conditions that promote the production of the compound, followed by extraction and purification processes to obtain the antibiotic in a usable form.

Research and Development

Ongoing research into cresomycin focuses on understanding its full spectrum of activity, optimizing its production, and exploring its potential in combination therapies. Studies are also being conducted to modify its structure to enhance its efficacy and reduce potential side effects.

Related Pages

• Antibiotic
• Streptomyces
• Mycobacterium tuberculosis
• Tuberculosis treatment